Factors supporting intrathecal humoral responses following viral encephalomyelitis

Journal of Virology

Volumn 85, Issue 6, 2011, Pages 2589-2598

  Phares, Timothy W ^a   Marques, Cristina P ^a   Stohlman, Stephen A ^a   Hinton, David R ^b   Bergmann, Cornelia C ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; CHEMOKINE RECEPTOR CXCR3; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 21; MESSENGER RNA; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ARTICLE; ASTROCYTE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENCEPHALOMYELITIS; HUMORAL IMMUNITY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE HOMING; LYMPHOCYTE MIGRATION; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; SPINAL CORD; UPREGULATION;

ANIMALS; ANTIBODIES, VIRAL; ANTIGEN-PRESENTING CELLS; CORONAVIRUS; CORONAVIRUS INFECTIONS; CYTOKINES; ENCEPHALOMYELITIS; MICE; MICE, INBRED C57BL; SPINAL CORD;

CORONAVIRUS;

EID: 79952374885     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02260-10     Document Type: Article

References (78)

1. Angelin-Duclos, C., G. Cattoretti, K. I. Lin, and K. Calame. 2000. Commitment of B lymphocytes to a plasma cell fate is associated with Blimp-1 expression in vivo. J. Immunol. 165:5462-5471.
2. Ansel, K. M., et al. 2000. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 406:309-314. (Pubitemid 30604409)
3. Belnoue, E., et al. 2008. APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells. Blood 111:2755-2764.
4. Benson, M. J., et al. 2008. The dependence of plasma cells and independence of memory B cells on BAFF and APRIL. J. Immunol. 180:3655-3659.
5. Bergmann, C. C., J. D. Altman, D. Hinton, and S. A. Stohlman. 1999. Inverted immunodominance and impaired cytolytic function of CD8+ T cells during viral persistence in the central nervous system. J. Immunol. 163:3379-3387.
6. Bergmann, C. C., T. E. Lane, and S. A. Stohlman. 2006. Coronavirus infection of the central nervous system: host-virus stand-off. Nat. Rev. Microbiol. 4:121-132.
7. Bleul, C. C., R. C. Fuhlbrigge, J. M. Casasnovas, A. Aiuti, and T. A. Springer. 1996. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J. Exp. Med. 184:1101-1109.
8. Bossen, C., et al. 2008. TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts. Blood 111:1004-1012. (Pubitemid 351213377)
9. Burgoon, M. P., et al. 2005. Laser-capture microdissection of plasma cells from subacute sclerosing panencephalitis brain reveals intrathecal disease-relevant antibodies. Proc. Natl. Acad. Sci. U. S. A. 102:7245-7250.
10. Cassese, G., et al. 2003. Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals. J. Immunol. 171:1684-1690. (Pubitemid 36966450)
11. Charo, I. F., and R. M. Ransohoff. 2006. The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 354:610-621.
12. Cole, K. E., et al. 1998. Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J. Exp. Med. 187:2009-2021.
13. Corcione, A., et al. 2004. Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 101:11064-11069.
14. Cyster, J. G. 2003. Homing of antibody secreting cells. Immunol. Rev. 194:48-60.
15. Cyster, J. G., K. M. Ansel, V. N. Ngo, D. C. Hargreaves, and T. T. Lu. 2002. Traffic patterns of B cells and plasma cells. Adv. Exp. Med. Biol. 512:35-41.
16. Farber, J. M. 1990. A macrophage mRNA selectively induced by gamma-interferon encodes a member of the platelet factor 4 family of cytokines. Proc. Natl. Acad. Sci. U. S. A. 87:5238-5242.
17. Griffin, D. E. 2003. Immune responses to RNA-virus infections of the CNS. Nat. Rev. Immunol. 3:493-502.
18. Griffin, D. E. 1981. Immunoglobulins in the cerebrospinal fluid: changes during acute viral encephalitis in mice. J. Immunol. 126:27-31. (Pubitemid 11218868)
19. Hargreaves, D. C., et al. 2001. A coordinated change in chemokine responsiveness guides plasma cell movements. J. Exp. Med. 194:45-56.
20. Hauser, A. E., et al. 2002. Chemotactic responsiveness toward ligands for CXCR3 and CXCR4 is regulated on plasma blasts during the time course of a memory immune response. J. Immunol. 169:1277-1282. (Pubitemid 34809169)
21. Holm, C., C. G. Nyvold, S. R. Paludan, A. R. Thomsen, and M. Hokland. 2006. Interleukin-21 mRNA expression during virus infections. Cytokine 33:41-45. (Pubitemid 43220351)
22. Hooper, D. C., T. W. Phares, M. J. Fabis, and A. Roy. 2009. The production of antibody by invading B cells is required for the clearance of rabies virus from the central nervous system. PLoS Negl. Trop. Dis. 3:e535.
23. Ireland, D. D., et al. 2009. RNase L mediated protection from virus induced demyelination. PLoS Pathog. 5:e1000602.
24. Kim, K. S., J. Y. Park, I. Jou, and S. M. Park. 2009. Functional implication of BAFF synthesis and release in gangliosides-stimulated microglia. J. Leukoc. Biol. 86:349-359.
25. Kimberley, F. C., J. P. Medema, and M. Hahne. 2009. APRIL in B-cell malignancies and autoimmunity. Results Probl. Cell Differ. 49:161-182.
26. Konforte, D., N. Simard, and C. J. Paige. 2009. IL-21: an executor of B cell fate. J. Immunol. 182:1781-1787.
27. Krumbholz, M., et al. 2005. BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J. Exp. Med. 201:195-200.
28. Leonard, W. J., and R. Spolski. 2005. Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nat. Rev. Immunol. 5:688-698.
29. Lin, H. Y., et al. 13 October 2010. Peptidoglycan induces interleukin-6 expression through the TLR2 receptor, JNK, c-Jun and AP-1 pathways in microglia. J. Cell. Physiol. doi:10.1002/jcp.22489. [Epub ahead of print.]
30. Lin, M. T., D. R. Hinton, N. W. Marten, C. C. Bergmann, and S. A. Stohlman. 1999. Antibody prevents virus reactivation within the central nervous system. J. Immunol. 162:7358-7368.
31. Linterman, M. A., et al. 2010. IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses. J. Exp. Med. 207:353-363.
32. Luster, A. D., and J. V. Ravetch. 1987. Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). J. Exp. Med. 166:1084-1097.
33. Mackay, F., and P. Schneider. 2008. TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties. Cytokine Growth Factor Rev. 19:263-276.
34. Mackay, F., P. Schneider, P. Rennert, and J. Browning. 2003. BAFF and APRIL: a tutorial on B cell survival. Annu. Rev. Immunol. 21:231-264.
35. MacLennan, I. C., et al. 2003. Extrafollicular antibody responses. Immunol. Rev. 194:8-18.
36. Magliozzi, R., S. Columba-Cabezas, B. Serafini, and F. Aloisi. 2004. Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. J. Neuroimmunol. 148:11-23. (Pubitemid 38229554)
37. Mantchev, G. T., C. S. Cortesao, M. Rebrovich, M. Cascalho, and R. J. Bram. 2007. TACI is required for efficient plasma cell differentiation in response to T-independent type 2 antigens. J. Immunol. 179:2282-2288.
38. + T cells within the central nervous system. J. Virol. 74:7903-7910.
39. +-T-cell expansion and trafficking following central nervous system infection. J. Virol. 77:2775-2778.
40. Minges Wols, H. A., G. H. Underhill, G. S. Kansas, and P. L. Witte. 2002. The role of bone marrow-derived stromal cells in the maintenance of plasma cell longevity. J. Immunol. 169:4213-4221.
41. Mohr, E., et al. 2009. Dendritic cells and monocyte/macrophages that create the IL-6/APRIL-rich lymph node microenvironments where plasmablasts mature. J. Immunol. 182:2113-2123.
42. Moisini, I., and A. Davidson. 2009. BAFF: a local and systemic target in autoimmune diseases. Clin. Exp. Immunol. 158:155-163.
43. Mokhtarian, F., C. M. Huan, C. Roman, and C. S. Raine. 2003. Semliki Forest virus-induced demyelination and remyelination-involvement of B cells and anti-myelin antibodies. J. Neuroimmunol. 137:19-31.
44. Moser, K., K. Tokoyoda, A. Radbruch, I. MacLennan, and R. A. Manz. 2006. Stromal niches, plasma cell differentiation and survival. Curr. Opin. Immunol. 18:265-270.
45. Mueller, S. N., et al. 2007. Regulation of homeostatic chemokine expression and cell trafficking during immune responses. Science 317:670-674. (Pubitemid 47229967)
46. Muller, M., S. Carter, M. J. Hofer, and I. L. Campbell. 2010. The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity-a tale of conflict and conundrum. Neuropathol. Appl. Neurobiol. 36:368-387.
47. O'Connor, B. P., et al. 2004. BCMA is essential for the survival of long-lived bone marrow plasma cells. J. Exp. Med. 199:91-98.
48. Owens, G. P., et al. 2007. Measles virus-specific plasma cells are prominent in subacute sclerosing panencephalitis CSF. Neurology 68:1815-1819. (Pubitemid 46791394)
49. Ozaki, K., et al. 2002. A critical role for IL-21 in regulating immunoglobulin production. Science 298:1630-1634. (Pubitemid 35387203)
50. Pachner, A. R., J. Brady, and K. Narayan. 2007. Antibody-secreting cells in the central nervous system in an animal model of MS: phenotype, association with disability, and in vitro production of antibody. J. Neuroimmunol. 190:112-120. (Pubitemid 47625618)
51. Pachner, A. R., L. Li, and K. Narayan. 2007. Intrathecal antibody production in an animal model of multiple sclerosis. J. Neuroimmunol. 185:57-63. (Pubitemid 46497441)
52. Parra, B., et al. 1999. IFN-gamma is required for viral clearance from central nervous system oligodendroglia. J. Immunol. 162:1641-1647. (Pubitemid 29307040)
53. Parsons, L. M., and H. E. Webb. 1982. Blood brain barrier disturbance and immunoglobulin G levels in the cerebrospinal fluid of the mouse following peripheral infection with the demyelinating strain of Semliki Forest virus. J. Neurol. Sci. 57:307-318.
54. Parsons, L. M., and H. E. Webb. 1992. IgG subclass responses in brain and serum in Semliki Forest virus demyelinating encephalitis. Neuropathol. Appl. Neurobiol 18:351-359.
55. Parsons, L. M., and H. E. Webb. 1982. Virus titres and persistently raised white cell counts in cerebrospinal fluid in mice after peripheral infection with demyelinating Semliki Forest virus. Neuropathol. Appl. Neurobiol 8:395-401.
56. Phares, T. W., R. B. Kean, T. Mikheeva, and D. C. Hooper. 2006. Regional differences in blood-brain barrier permeability changes and inflammation in the apathogenic clearance of virus from the central nervous system. J. Immunol. 176:7666-7675.
57. Phares, T. W., et al. 2009. Target-dependent B7-H1 regulation contributes to clearance of central nervous system infection and dampens morbidity. J. Immunol. 182:5430-5438.
58. Ramakrishna, C., C. C. Bergmann, R. Atkinson, and S. A. Stohlman. 2003. Control of central nervous system viral persistence by neutralizing antibody. J. Virol. 77:4670-4678.
59. Rauch, M., R. Tussiwand, N. Bosco, and A. G. Rolink. 2009. Crucial role for BAFF-BAFF-R signaling in the survival and maintenance of mature B cells. PLoS One 4:e5456.
60. Rolink, A. G., and F. Melchers. 2002. BAFFled B cells survive and thrive: roles of BAFF in B-cell development. Curr. Opin. Immunol. 14:266-275.
61. Rolink, A. G., J. Tschopp, P. Schneider, and F. Melchers. 2002. BAFF is a survival and maturation factor for mouse B cells. Eur. J. Immunol. 32:2004-2010.
62. Savarin, C., S. A. Stohlman, R. Atkinson, R. M. Ransohoff, and C. C. Bergmann. 2010. Monocytes regulate T cell migration through the glia limitans during acute viral encephalitis. J. Virol. 84:4878-4888.
63. Serafini, B., B. Rosicarelli, R. Magliozzi, E. Stigliano, and F. Aloisi. 2004. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol. 14:164-174. (Pubitemid 38656388)
64. Serafini, B., et al. 2010. Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation. J. Neuropathol. Exp. Neurol. 69:677-693.
65. Shapiro-Shelef, M., and K. Calame. 2005. Regulation of plasma-cell development. Nat. Rev. Immunol. 5:230-242.
66. Shulga-Morskaya, S., et al. 2004. B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation. J. Immunol. 173:2331-2341. (Pubitemid 39063089)
67. Spolski, R., and W. J. Leonard. 2010. IL-21 and T follicular helper cells. Int. Immunol. 22:7-12.
68. Thangarajh, M., T. Masterman, J. Hillert, S. Moerk, and R. Jonsson. 2007. A proliferation-inducing ligand (APRIL) is expressed by astrocytes and is increased in multiple sclerosis. Scand. J. Immunol. 65:92-98.
69. Tschen, S. I., et al. 2002. Recruitment kinetics and composition of antibody-secreting cells within the central nervous system following viral encephalomyelitis. J. Immunol. 168:2922-2929.
70. Tschen, S. I., et al. 2006. CNS viral infection diverts homing of antibody-secreting cells from lymphoid organs to the CNS. Eur. J. Immunol. 36:603-612.
71. Tyor, W. R., S. Wesselingh, B. Levine, and D. E. Griffin. 1992. Long term intraparenchymal Ig secretion after acute viral encephalitis in mice. J. Immunol. 149:4016-4020.
72. Van Wagoner, N. J., and E. N. Benveniste. 1999. Interleukin-6 expression and regulation in astrocytes. J. Neuroimmunol. 100:124-139.
73. Vogelzang, A., et al. 2008. A fundamental role for interleukin-21 in the generation of T follicular helper cells. Immunity 29:127-137.
74. Wilms, H., et al. 2010. Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1beta, TNF-alpha and IL-6 in an in-vitro model of brain inflammation. J. Neuroinflammation 7:30.
75. Winter, O., et al. 2010. Megakaryocytes constitute a functional component of a plasma cell niche in the bone marrow. Blood 116:1867-1875.
76. Zhou, J., S. A. Stohlman, N. W. Marten, and D. R. Hinton. 2001. Regulation of matrix metalloproteinase (MMP) and tissue inhibitor of matrix metalloproteinase (TIMP) genes during JHMV infection of the central nervous system. Adv. Exp. Med. Biol. 494:329-334.
77. Zotos, D., et al. 2010. IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism. J. Exp. Med. 207:365-378.
78. Zuo, J., et al. 2006. Mouse hepatitis virus pathogenesis in the central nervous system is independent of IL-15 and natural killer cells. Virology 350:206-215. (Pubitemid 43850588)